The sequence of improvement of the symptoms encountered in patients with panic disorder.
Patients who meet DSM-III-R criteria for a diagnosis of panic disorder often show a complex mixture of psychopathological symptoms, including panic attacks (spontaneous and situational), anxiety (anticipatory and generalized), phobias (fear and avoidance), depression/dysphoria, and social and occupational disability. Various theories about the pathogenesis of these symptoms have been advanced that focus on a given symptom (e.g., panic, phobia) being primary in these disorders, with concurrent symptoms seen as epiphenomena or as secondary and reactive to a core symptom. This study, conducted on a large sample of panic disorder patients (N = 1,168), examines the temporal sequential pattern of symptom improvement in these patients, and explores how these relationships relate to various pathogenic theories. Our multiple analyses, when considered together, tend not to support any pathogenic theory that views a given symptom as being central to the overall disorder; our findings have obvious implications for theoreticians and clinicians interested in the study and treatment of panic and anxiety disorders.
Deltito
J A
JA
Department of Psychiatry, Cornell University Medical College, White Plains, NY.
Argyle
N
N
Buller
R
R
Nutzinger
D
D
Ottosson
J O
JO
Brandon
S
S
Mellergard
M
M
Shera
D
D
D000328:Adult; D000525:Alprazolam / Q000627:therapeutic use; D001008:Anxiety Disorders / Q000175:diagnosis* / Q000188:drug therapy / Q000523:psychology; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D007099:Imipramine / Q000627:therapeutic use; D008297:Male; D010043:Outcome and Process Assessment, Health Care; D010200:Panic; D010919:Placebos; D011569:Psychiatric Status Rating Scales; D012074:Remission Induction; D012720:Severity of Illness Index
D010919:Placebos; D007099:Imipramine; D000525:Alprazolam